Inventor · disambiguated record
Jason W. Skudlarek
Also filed as: SKUDLAREK JASON · SKUDLAREK JASON W
27 granted patents·10 pending applications·242 citations·filing 2005–2023
96Inventor score
Files withMERCK SHARP & DOHME17MERCK SHARP & DOHME LLC6KUDUK SCOTT D4BESHORE DOUGLAS C2ALTIRIS THERAPEUTICS INC1
Top patents by PatentIndex Score
37 records- 0197US9586934B22-pyridyloxy-4-methyl orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Mar 7, 2017·25 cites·14 claims
- 0296US9624197B22-pyridylamino-4-nitrile-piperidinyl orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Apr 18, 2017·24 cites·11 claims
- 0396US9617246B2Thioether-piperidinyl orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Apr 11, 2017·18 cites·14 claims
- 0496US9556190B2Piperidinyloxy lactone orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Jan 31, 2017·18 cites·16 claims
- 0596US8940898B2Piperidinyl alkyne orexin receptor antagonistsKUDUK SCOTT D·Filed 2012·Granted Jan 27, 2015·25 cites·16 claims
- 0695US9586950B22-pyridyloxy-3-ester-4-nitrile orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Mar 7, 2017·17 cites·12 claims
- 0795US9556145B22-pyridyloxy-4-ester orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Jan 31, 2017·17 cites·15 claims
- 0895US9546152B22-pyridyloxy-3-substituted-4-nitrile orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Jan 17, 2017·17 cites·13 claims
- 0994US9156819B22-pyridyloxy-4-nitrile orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2012·Granted Oct 13, 2015·34 cites·28 claims
- 1092US11919894B2Pro drugs of PDE10 compoundsMERCK SHARP & DOHME LLC·Filed 2022·Granted Mar 5, 2024·2 cites·54 claims
- 1190US9314468B2Chemokine receptor modulatorsALTIRIS THERAPEUTICS INC·Filed 2012·Granted Apr 19, 2016·21 cites·8 claims
- 1283US9676751B22-amino-3-ester-pyridl orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Jun 13, 2017·3 cites·14 claims
- 1380US9725434B2Hydroxy-substituted orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Aug 8, 2017·3 cites·12 claims
- 1479US9745284B22-pyridyloxy-4-ether orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Aug 29, 2017·2 cites·6 claims
- 1579US8338448B2Chemokine receptor modulatorsCLARK MICHAEL P·Filed 2009·Granted Dec 25, 2012·5 cites·11 claims
- 1678US9765057B23-ester-4 substituted orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted Sep 19, 2017·2 cites·11 claims
- 1778US9643955B22-pyridyloxy-3-nitrile-4-substituted orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2013·Granted May 9, 2017·2 cites·10 claims
- 1877US8772276B2Alkyne benzotriazole derivativesKUDUK SCOTT D·Filed 2012·Granted Jul 8, 2014·2 cites·17 claims
- 1976US12215101B2Pro drugs of PDE10 compoundsMERCK SHARP & DOHME LLC·Filed 2023·Granted Feb 4, 2025·0 cites·3 claims
- 2072US8557992B2Heterocyclic fused phenanthrolinone M1 receptor positive allosteric modulatorsKUDUK SCOTT D·Filed 2011·Granted Oct 15, 2013·1 cites·13 claims
- 2171US8785481B2Ether benzotriazole derivativesBESHORE DOUGLAS C·Filed 2011·Granted Jul 22, 2014·2 cites·13 claims
- 2270US10150751B2Pyrrolidine orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Dec 11, 2018·1 cites·9 claims
- 2368US8975286B2Ether benzotriazole derivativesDUDKIN VADIM Y·Filed 2010·Granted Mar 10, 2015·1 cites·18 claims
- 2465US2025312362A1INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOFMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2561US2025326713A1INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOFMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2657US2023118665A1Novel thermostable lipid nanoparticle and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2756US2024083910A1Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesvirusesBERGER RICHARD·Filed 2021·Application pending·0 cites
- 2856US2024059693A1Fused bicyclic pyrazole derivatives and methods of use thereof for the treatment of herpesvirusesMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2954US2024067657A1Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesvirusesARMACOST KIRA A·Filed 2021·Application pending·0 cites
- 3050US9975876B22-pyridyloxy-3-ester-4-ether orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted May 22, 2018·0 cites·2 claims
- 3148US2023066268A1Indazole derivatives and methods of use thereof for the treatment of herpes virusesCOOKE ANDREW JOHN·Filed 2020·Application pending·0 cites
- 3248US2016102073A12-hydroxymethyl-substituted orexin receptor antagonistsKUDUK SCOTT D·Filed 2014·Application pending·0 cites
- 3343US9987255B25,5-bicyclic oxazole orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Jun 5, 2018·0 cites·12 claims
- 3443US2006063828A11,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereofWEINGARTEN M D·Filed 2005·Application pending·0 cites
- 3541US9139576B2Aminomethyl biaryl benzotriazole derivativesBESHORE DOUGLAS C·Filed 2012·Granted Sep 22, 2015·0 cites·16 claims
- 3641US2006100226A12-Thiopyrimidinones as therapeutic agentsSIKORSKI JAMES A·Filed 2005·Application pending·0 cites
- 3739US10000499B2Methyl diazepane orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Jun 19, 2018·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Jason W. Skudlarek files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →